PPARGC1A and neuromuscular disease: The increase of KBs concentration, the reduction of blood glucose together with the involvement of many important pathways (e.g., IGF-1/AKT/mTor, AMPK/PGC1α) has shown to be a potential therapeutic weapon against many neurological and neuromuscular diseases.